Hindustan Bio Sciences Limited (BOM:532041)
India · Delayed Price · Currency is INR 6.71
+0.05 (0.75%)
At close: Aug 21, 2026
Hindustan Bio Sciences Revenue
Hindustan Bio Sciences had revenue of 4.02M INR in the twelve months ending June 30, 2026, down -44.38% year-over-year. In the fiscal year ending March 31, 2026, Hindustan Bio Sciences had annual revenue of 7.37M, down -9.37%.
Revenue (ttm)
4.02M
Revenue Growth
-44.38%
P/S Ratio
17.11
Revenue / Employee
2.01M
Employees
2
Market Cap
68.78M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 7.37M | -762.00K | -9.37% |
| Mar 31, 2025 | 8.13M | -2.40M | -22.75% |
| Mar 31, 2024 | 10.53M | 1.30M | 14.15% |
| Mar 31, 2023 | 9.22M | 4.92M | 114.19% |
| Mar 31, 2022 | 4.31M | -6.01M | -58.27% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Vellora Impact | 1.45B |
| Vivanza Biosciences | 1.17B |
| Jayatma Industries | 265.31M |
| ObjectOne Information Systems | 147.12M |
| Ganon Products | 79.22M |
| Ganga Pharmaceuticals | 28.28M |
| Sunraj Diamond Exports | 25.47M |
| BGIL Films & Technologies | 9.77M |